This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 3341
Title
Activation of the innate immune response leads to Activation of gluten-reactive CD4+ T cells
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
|---|---|---|---|---|---|---|
| Gluten-driven immune activation leading to celiac disease in genetically predisposed individuals | adjacent | Moderate | Antonio Fernandez Dumont (send email) | Under development: Not open for comment. Do not cite | Under Review |
Taxonomic Applicability
| Term | Scientific Term | Evidence | Link |
|---|---|---|---|
| human | Homo sapiens | High | NCBI |
Sex Applicability
| Sex | Evidence |
|---|---|
| Male | Moderate |
| Female | High |
Life Stage Applicability
| Term | Evidence |
|---|---|
| Juvenile | Moderate |
| Adult | Moderate |
| All life stages | Moderate |
Key Event Relationship Description
Innate immune activation in the gastrointestinal tract will activate dendritic cells resulting in the processing and expression of specific antigens followed by migration to the draining lymphnodes. Alternatively, the antigens are captured by dendritic cells present in the Peyer's patches. Subsequently interaction between these activated, antigen-loaded dendritic cells with naive CD4 T cells expressing antigen specific T cell receptors will result in activation of these CD4 T cells, followed by proliferation and secretion of cytokines.
Evidence Collection Strategy
Evidence was collected through a combination of literature searches and expert consultations. Experts contributed by reviewing drafted material asynchronously and participating in online discussions to refine the evidence base. Additionally, they provided key articles relevant to the topic, which served as a foundation for further literature searches in Scopus, PubMed, and Google Scholar. Keywords were tailored to each key event (KE) and key event relationship (KER) to ensure comprehensive coverage of relevant studies. The collected literature was systematically categorized in an Excel spreadsheet based on its relevance to specific KEs and KERs within the AOP. This approach facilitated the organization of data supporting different aspects of the pathway.
Evidence Supporting this KER
Essential textbook knowledge
Biological Plausibility
Celiac disease is caused by an intolerance to gluten food proteins. There is an exceptionally strong association between the occurrence of celiac disease and the presence of HLA-DQ2 and/or HLA-DQ8 molecules. This association is explained by the observation that CD4 T cells specific for modified gluten peptides bound to either HLA-DQ2 or HLA-DQ8 are typically found in patients but not in healthy individuals. CD4 T cells belong to the adaptive immune system. The initiation of adaptive immune responses depends on activation of the innate immune system, dendritic cells in particular. Dendritic cells can be activated through pattern recognition receptors (PRRs) that bind pathogen associated molecular patterns (PAMPs) like bacterial cell wall components (LPS) and viral double-stranded ribonucleic acid (dsRNA). Upon activation of dendritic cells, they process antigen derived from such pathogens and present them to adaptive T cells, resulting in the initiation of long-lasting T cell responses to eradicate the pathogens. Thus, innate immune activation is required for the initiation of disease-causing gluten-specific CD4 T cells.
Importantly, activated gluten-specific CD4 T cells typically produce cytokines, including IFN gamma, a cytokine known to enhance the expression of HLA-molecules, like HLA-DQ2 and HLA-DQ8. This thus feeds back into MEI, formation of HLA-DQ-gluten complexes, and constitutes an amplification loop enhancing the adaptive CD4 T cell response to gluten.
Empirical Evidence
The fact that innate immune activation precedes adaptive immune response is essential textbook knowledge.
Uncertainties and Inconsistencies
There are no known uncertainties or inconsistencies.
Known modulating factors
Gender is a strong modulator as females have an approximately 2 times higher chance of developing celiac disease. Other potential modulating factors are the composition of the intestinal microbiota. IgA deficiency is known to increase the risk of development of celiac disease.
| Modulating Factor (MF) | MF Specification | Effect(s) on the KER | Reference(s) |
|---|---|---|---|
Quantitative Understanding of the Linkage
Response-response Relationship
Time-scale
Innate immune responses are immediate upon exposure to pathogens followed by adaptive immune responses developing over a period of 1 to 2 weeks.
Known Feedforward/Feedback loops influencing this KER
Mucosal tolerance maintains homeostasis in the gastrointestinal tract by suppressing immune responses to harmless food derived antigens. In part this is achieved by the activity of T regulatory cells that can suppress the activity of effector T cells, like the gluten-specific CD4 T cells typically found in patients with celiac disease.
Domain of Applicability
Celiac disease, as it is currently understood, is a human-specific autoimmune disorder. Some animal models have been developed to reproduce aspects of the disease, but celiac disease is exclusive to humans. (Marietta et al., 2011). It is particularly applicable during childhood and adulthood, as immune responses to gluten exposure are most pronounced in these life stages, with less prominent mechanisms observed in early infancy (Meresse et al., 2004; Qiao et al., 2011). While this KER applies to both sexes, it is important to note that females are more likely to be affected by celiac disease, and sex-based differences in immune response can influence clinical outcomes (Dieterich, 1997; Lundin et al., 1993).
References
-
- Essential textbook knowledge
-
Meresse, B., Cerf-Bensussan, N., & Pender, S. L. (2004). The role of tissue transglutaminase in celiac disease. Current Opinion in Gastroenterology, 20(3), 269-274.
-
Qiao, S. W., et al. (2011). Gluten-specific immune responses and celiac disease. Immunology and Cell Biology, 89(2), 180-187. https://doi.org/10.1038/icb.2010.80
-
Dieterich, W. (1997). Celiac disease: immunopathogenesis and clinical features. Journal of Immunology, 158(7), 3244-3250.
-
Lundin, K. E., et al. (1993). The role of T cells in celiac disease. Gastroenterology, 105(4), 1021-1029. https://doi.org/10.1016/0016-5085(93)90133-V